Eddie Pan

Eddie Pan

Expertise: Institutional Investments, Insider Activity, Disruptive Innovations

Education: BBA, Finance, James Madison University

About Eddie:
Eddie Pan specializes in institutional investments and insider activity. He has been enamored with hedge funds since he began investing and regularly collaborates with industry executives to craft editorial pieces. Tracking the investments of institutional investors and insiders can provide a vast array of knowledge that is scarcely covered.

After receiving his BBA in Finance from James Madison University, Eddie began his career at Accenture as an analyst. Today, he writes for InvestorPlace’s Today’s Market team, which centers on the latest news involving popular stocks.

Eddie got his start in the financial media world by publishing articles on top-performing hedge funds and their investment strategies on Substack. He still publishes pieces on his Substack today.

Common Stocks and Uncommon Profits by Philip A. Fisher is Eddie’s favorite investment book. Fisher’s 15 Points have heavily influenced his investment strategy.

Recent Articles

RIVN Stock Alert: Rivian Chief Commercial Officer Kjell Gruner Resigns

Two Rivian executives have announced their resignations this month with Chief Commercial Officer Kjell Gruner announcing his departure today.

Cantor Fitzgerald Just Raised Its Price Target on Coursera (COUR) Stock

COUR stock is trading higher after the educational company reported beats on both revenue and EPS for the second quarter.

SEC Charges Citron’s Andrew Left in $20 Million Fraud Scheme: What You Need to Know

The SEC has charged Citron Research and its founder, Andrew Left, with federal securities law violations involving misleading statements.

QS Stock: Why Did QuantumScape Report Wider Losses Than Expected for Q2?

QS stock is sinking lower after the company's second quarter EPS loss of 25 cents fell below the analyst estimate for a loss of 22 cents.

Warren Buffett Is Dumping Bank of America (BAC) Stock. What’s Going On?

Warren Buffett and Berkshire Hathaway have sold $2.3 billion of BAC stock during the past six trading days. Here's what you need to know.